Mary Spellman

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

Amy S. Paller, Wynnis L. Tom, Mark Lebwohl et al. · Journal of the American Academy of Dermatology · 2016 · 565 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis

Alice B. Gottlieb, James G. Krueger, Ross Bright et al. · Journal of the American Academy of Dermatology · 2000 · 206 citations

Medicine, Dermatology, Immunology +15

Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis

Lawrence F. Eichenfield, Robert S. Call, Douglass W. Forsha et al. · Journal of the American Academy of Dermatology · 2017 · 149 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects

Jill A. Poole, Jianfeng Meng, Mitchell E. Reff et al. · Journal of Allergy and Clinical Immunology · 2005 · 86 citations

Life Sciences, Immunology, Allergy +16

The Efficacy and Tolerability of Clobetasol Propionate Foam 0.05% in the Treatment of Mild to Moderate Plaque-type Psoriasis of Nonscalp Regions

Alice B. Gottlieb, Rosanne Odom Ford, Mary Spellman · Journal of Cutaneous Medicine and Surgery · 2003 · 67 citations

Pharmacy, Dermatology, Pharmacotherapy +9